| Ticker | MIRM |
|---|---|
| ISIN | US6047491013 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the treatment of Alagille syndrome and biliary atresia disease. It also develops Volixibat drug for treatment of intrahepatic cholestasis of pregnancy and pri...
El precio actual de Mirum Pharmaceuticals, Inc. (MIRM) es de 92,48 , con una variación del 1,08%.
Mirum Pharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones